Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGOBSERVATIONAL

Mesogastrium Metastasis in Colon Cancer

Right Gastroepiploic Mesentery Metastasis in Advanced Colon Cancer Locating at or Close to the Hepatic Flexure

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.

Who May Be Eligible (Plain English)

Who May Qualify: - Age between 18 and 75 years - American Society of Anesthesiologists (ASA) score I to III - A biopsy proven histological diagnosis of colorectal carcinoma - Preoperative staging cT2-4aN0M0 or cTanyN+M0 - tumor located at hepatic flexure or transverse colon close to flexures - Undergoing complete mesocolic excision with right gastric mesentery resection - Patients have to be aware of the aim of the trial, and have signed the willing to sign a consent form. Who Should NOT Join This Trial: - Synchronous colorectal carcinoma - Clinical evidence of metastasis - History of colorectal cancer or other malignant tumors - Preoperative staging cT1N0 or cT4bNany - Emergency procedure Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Age between 18 and 75 years * American Society of Anesthesiologists (ASA) score I to III * A biopsy proven histological diagnosis of colorectal carcinoma * Preoperative staging cT2-4aN0M0 or cTanyN+M0 * tumor located at hepatic flexure or transverse colon close to flexures * Undergoing complete mesocolic excision with right gastric mesentery resection * Patients have to be aware of the aim of the trial, and have signed the informed consent. Exclusion Criteria: * Synchronous colorectal carcinoma * Clinical evidence of metastasis * History of colorectal cancer or other malignant tumors * Preoperative staging cT1N0 or cT4bNany * Emergency procedure

Locations (1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
Wuhan, Hubei, China